Suppr超能文献

用于人二倍体成纤维细胞微载体培养的低血清培养基的开发。

Low-serum medium development for human diploid fibroblast microcarrier cultures.

作者信息

Forestell S P, Kalogerakis N, Behie L A

机构信息

Pharmaceutical Production Research Facility (PPRF), Faculty of Engineering, University of Calgary, Alberta, Canada.

出版信息

Appl Microbiol Biotechnol. 1992 Nov;38(2):165-72. doi: 10.1007/BF00174462.

Abstract

A new medium supplement mixture, PPRF92, has been developed to enable the serial subculture of human diploid fibroblasts (MRC-5 cells) on microcarriers. Furthermore, the PPRF92 supplements enable cell growth at serum levels as low as 1%. Through an optimization programme, the PPRF92 supplements have evolved into a simple mixture with the concentrations of key components at a level that makes the overall cost very competitive with medium containing 10% foetal bovine serum (FBS). Furthermore, the PPRF92 supplement mixture is most efficacious when FBS is replaced with the cheaper, and more widely available, adult bovine serum (ABS). Although medium exchange with serum is necessary in order to achieve confluence on microcarriers, the PPRF92 mixture is only necessary at the initiation of each passage. Using the medium replenishment protocol that has been developed in our laboratory, MRC-5 cells were successfully serially passaged through 13 bead-to-bead transfers on microcarriers in DMEM/F12 medium enriched with the PPRF92 supplement mixture reported here, and 1% ABS.

摘要

一种新的培养基补充混合物PPRF92已被开发出来,用于使人二倍体成纤维细胞(MRC-5细胞)在微载体上进行连续传代培养。此外,PPRF92补充剂能使细胞在低至1%的血清水平下生长。通过优化程序,PPRF92补充剂已演变成一种简单的混合物,关键成分的浓度处于使总成本与含10%胎牛血清(FBS)的培养基相比极具竞争力的水平。此外,当用更便宜且更易获得的成年牛血清(ABS)替代FBS时,PPRF92补充剂混合物的效果最佳。虽然为了在微载体上达到汇合需要用血清进行培养基更换,但PPRF92混合物仅在每次传代开始时需要。使用我们实验室开发的培养基补充方案,MRC-5细胞在富含本文报道的PPRF92补充剂混合物和1% ABS的DMEM/F12培养基中,成功地在微载体上通过13次逐珠传代进行了连续传代。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验